Analytica (ASX: ALT) Share Price and News
Price
$0.001
Movement
– ( )
as at 30 Aug - Closed (20 mins delayed)
52 Week Range
$0.001 - $0.002
1 Year Return
0.0
Analytica Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
$0.001
Day Change
– ( )
52 Week Range
$0.001 - $0.002
Yesterday's Close
$0.001
Today's Open
–
Days Range
– - –
Volume
0
Avg. Volume (1 month)
0
Turnover
$0
as at 30 Aug - Closed
Should you invest $1,000 in Ramsay Health Care Limited right now?
Before you buy Ramsay Health Care Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys...
See The 5 Stocks *Returns as of 6 March 2025
Analytica (ASX: ALT)
Latest News
Investing
4 ASX stocks getting hammered today
Investing
Why Analytica Limited shares were slammed 29% today
Investing
5 ASX stocks falling to the market today
Investing
5 of the best companies presenting at Australia Biotech Invest 2014
Investing
3 speculative stocks with sky-high potential
Investing
7 speculative stocks deserving your attention
ALT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| 27th Mar 2025 2025-03-27T18:46:38 | DISTRIBUTION DATES | YesNo | 6:46pm | 3 | 57k |
| 12th Mar 2025 2025-03-12T18:08:46 | INTERIM FINANCIAL REPORT FOR THE HALF YEAR ENDED 31 DECEMBER | YesNo | 6:08pm | 30 | 914k |
| 5th Mar 2025 2025-03-05T18:40:36 | NUMBER OF OUTSTANDING UNITS AND FUND FLOWS | YesNo | 6:40pm | 5 | 129k |
| 21st Feb 2025 2025-02-21T18:45:24 | INDICATIVE 2025 FUND DISTRIBUTIONS CALENDAR | YesNo | 6:45pm | 5 | 195k |
| 6th Feb 2025 2025-02-06T18:51:03 | NUMBER OF OUTSTANDING UNITS AND FUND FLOWS | YesNo | 6:51pm | 6 | 173k |
| 9th Jan 2025 2025-01-09T18:16:04 | COMPONENTS OF DISTRIBUTIONS | YesNo | 6:16pm | 3 | 230k |
| 7th Jan 2025 2025-01-07T18:54:47 | NUMBER OF OUTSTANDING UNITS AND FUND FLOWS | YesNo | 6:54pm | 5 | 159k |
| 7th Jan 2025 2025-01-07T18:48:22 | DISTRIBUTION REINVESTMENT PLAN PRICES | YesNo | 6:48pm | 3 | 68k |
| 7th Jan 2025 2025-01-07T18:43:22 | FINAL DISTRIBUTION ANNOUNCEMENT | YesNo | 6:43pm | 3 | 68k |
| 6th Jan 2025 2025-01-06T18:27:36 | REVISED ESTIMATED DISTRIBUTION ANNOUNCEMENT | YesNo | 6:27pm | 2 | 101k |
About Analytica
Analytica Ltd. engages in the design development, and supply of class 1 and class 2 medical devices. It operates through the following segment: Medical Devices and Corporate. The Medical Devices segment is consist of AutoStart Burette, PeriCoach, and ELF 2. The Corporate segment includes all other operations including the administration, and associated listed public company expenditure. The company is headquartered in Brisbane, Australia.
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Dr Michael Monsour | Executive ChairmanExecutive Director | Jun 2004 |
Dr Monsour has interests in Queensland medical and dental centres. He operates a medical management company, which provides management support to medical and dental practitioners. He is the principal of Godbar Software (established 1988).
|
| Mr Ross Mangelsdorf | Executive Director | Sep 2010 |
Mr Mangelsdorf performs the function of Chief Financial Officer. Mr Mangelsdorf is a director/partner of a chartered accounting firm for 38 years.
|
| Dr Peter B Corr | Non-Executive Director | May 2017 |
Dr Corr has experience in the discovery and development of medicines as well as the sale of assets to multinational corporations. Dr Corr co-founded and is Managing General Partner of Auven Therapeutics. Dr Corr was previously a Professor of Medicine and Pharmacology at Washington University for 18 years.
|
| Mr Bryan Dulhunty | Company Secretary | Oct 2012 |
-
|
| Bryan Dulhunty | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Halonna Pty Ltd | 696,890,604 | 15.10% |
| Inov8 Llc | 360,790,157 | 7.82% |
| Mr Mohammad Manzur Murshed | 250,999,999 | 5.44% |
| Mpammpty Ltd | 233,042,390 | 5.05% |
| M P Monsour Medical Practice Pty Ltd | 156,379,178 | 3.39% |
| Ignatius Lip Pty Ltd | 151,073,534 | 3.27% |
| Dr Teresa Margaret Mullins & Dr Peter James Mullins | 117,062,340 | 2.54% |
| Mr Mark Arundel & Mrs Sigrid Arundel | 100,000,000 | 2.17% |
| Mr Gerry Van Ameyden | 91,454,487 | 1.98% |
| Dr Kelvin Richards Khong | 62,464,171 | 1.35% |
| Wins Asset Management Pty Ltd | 56,000,000 | 1.21% |
| Tambien Pty Ltd | 51,633,561 | 1.12% |
| Fitzwill Superannuation Pty Ltd | 50,000,000 | 1.08% |
| Cmonsuper Pty Ltd | 49,632,352 | 1.08% |
| Mr Richard Thomas Hayward Daly & Mrs Sarah Kay Daly | 49,453,538 | 4.07% |
| Neatford Pty Ltd | 40,009,545 | 0.87% |
| Mr Mark Overell Tagg Arundel & Mrs Sigrid Jo Anne Arundel | 40,000,000 | 0.87% |
| Mrs Sabina Lip | 38,171,429 | 0.83% |
| BNP Paribas Nominees Pty Ltd | 36,517,730 | 0.79% |
| 1215 Capital Pty Ltd | 34,650,800 | 0.75% |